全球栓塞治疗市场规模、份额、趋势和成长分析报告（2026-2034年）

预计栓塞治疗市场将从 2025 年的 54.4 亿美元成长到 2034 年的 112.4 亿美元，2026 年至 2034 年的复合年增长率为 8.39%。

由于微创手术在各种疾病治疗中的应用日益广泛，全球栓塞术市场正经历显着成长。栓塞术广泛用于阻断肿瘤、异常血管或出血部位的血流，已成为肿瘤学、神经学和血管疾病的重要治疗选择。癌症和血管疾病发生率的上升是推动市场成长的主要因素。

栓塞材料和影像技术的进步提高了栓塞治疗的安全性和有效性。微球、弹簧圈和液体栓塞剂等先进栓塞剂的研发，使得复杂疾病的治疗更加精准。此外，医疗专业人员对微创疗法益处的认识不断提高，也推动了微创疗法的广泛应用。

由于介入放射学领域的持续研究和创新，栓塞治疗市场预计未来将进一步扩张。先进影像系统的普及和专业治疗中心的增加将推动市场成长。随着医疗机构不断优先考虑微创手术，栓塞治疗有望成为全球日益重要的治疗方法。

目录

第一章：引言

第二章执行摘要

第三章 市场变数、趋势与框架

• 市场谱系展望
• 渗透率和成长前景分析
• 价值链分析
• 法律规范
  • 标准与合规性
  • 监管影响分析
• 市场动态
  • 市场驱动因素
  • 市场限制因素
  • 市场机会
  • 市场挑战
• 波特五力分析
• PESTLE分析

第四章 全球栓塞治疗市场：依产品分类

• 市场分析、洞察与预测
• 栓塞线圈
• 栓塞剂
• 可拆卸气球
• 栓塞塞系统
• 辅助设备

第五章 全球栓塞治疗市场：依应用领域划分

• 市场分析、洞察与预测
• 肿瘤学
• 週边血管疾病
• 泌尿系统和肾臟病学
• 神经病学
• 消化器官系统疾病

第六章 全球栓塞治疗市场：依手术方式划分

• 市场分析、洞察与预测
• 经导管动脉栓塞术
• 经导管动脉放射乳剂/选择性体内放射疗法
• 经动脉化疗栓塞术

第七章 全球栓塞治疗市场：依最终使用者划分

• 市场分析、洞察与预测
• 医院和诊所
• 门诊手术中心
• 其他最终用户

第八章 全球栓塞治疗市场：按地区划分

• 区域分析
• 北美市场分析、洞察与预测
  • 我们
  • 加拿大
  • 墨西哥
• 欧洲市场分析、洞察与预测
  • 英国
  • 法国
  • 德国
  • 义大利
  • 俄罗斯
  • 其他欧洲国家
• 亚太市场分析、洞察与预测
  • 印度
  • 日本
  • 韩国
  • 澳洲
  • 东南亚
  • 其他亚太国家
• 拉丁美洲市场分析、洞察与预测
  • 巴西
  • 阿根廷
  • 秘鲁
  • 智利
  • 其他拉丁美洲国家
• 中东和非洲市场分析、洞察与预测
  • 沙乌地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中东和非洲国家

第九章 竞争情势

• 最新趋势
• 公司分类
• 供应链和销售管道合作伙伴（根据现有资讯）
• 市场占有率和市场定位分析（基于现有资讯）
• 供应商情况（基于现有资讯）
• 策略规划

第十章：公司简介

• 主要公司的市占率分析
• 公司简介
  • Boston Medical Corporation
  • Terumo Corporation
  • Medtronic Plc
  • Johnson & Johnson
  • Stryker Corporation
  • Sirtex Medical Limited
  • Abbott Laboratories
  • Acandis GmbH
  • Balt Extrusion SAS
  • Cook Medical LLC
  • Kaneka Corporation
  • Penumbra Inc
  • Merit Medical Systems Inc
  • Meril Life Sciences Pvt. Ltd
  • Cardiva Medical Inc

The Embolotherapy Market size is expected to reach USD 11.24 Billion in 2034 from USD 5.44 Billion (2025) growing at a CAGR of 8.39% during 2026-2034.

The global embolotherapy market is experiencing significant growth due to the increasing adoption of minimally invasive procedures for the treatment of various medical conditions. Embolotherapy is widely used to block blood flow to tumors, abnormal vessels, or bleeding sites, making it an important treatment option in oncology, neurology, and vascular disorders. The growing prevalence of cancer and vascular diseases is a key driver for the market.

Advancements in embolization materials and imaging technologies have improved the safety and effectiveness of embolotherapy procedures. The development of advanced embolic agents such as microspheres, coils, and liquid embolics has enabled more precise treatment of complex conditions. Additionally, increasing awareness among healthcare professionals about the benefits of minimally invasive therapies is encouraging wider adoption.

Looking ahead, the embolotherapy market is expected to expand further due to ongoing research and innovation in interventional radiology. The increasing availability of advanced imaging systems and specialized treatment centers will support market growth. As healthcare providers continue to prioritize minimally invasive procedures, embolotherapy is likely to become an increasingly important treatment approach worldwide.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product

• Embolization Coil
• Embolic Agents
• Detachable Balloons
• Embolic Plug Systems
• Support Devices

By Application

• Oncology
• Peripheral Vascular Diseases
• Urology and Nephrology
• Neurology
• GIT Disorders

By Procedure

• Transcatheter Arterial Embolization
• Transcatheter Arterial Radioembolization/Selective Internal Radiation Therapy
• Transarterial Chemoembolization

By End User

• Hospitals and Clinics
• Ambulatory Surgical Centers
• Other End Users

COMPANIES PROFILED

• Boston Medical Corporation, Terumo Corporation, Medtronic plc, Johnson Johnson, Stryker Corporation, Sirtex Medical Limited, Abbott Laboratories, Acandis GmbH, Balt Extrusion SAS, Cook Medical LLC, Kaneka Corporation, Penumbra Inc, Merit Medical Systems Inc, Meril Life Sciences Pvt Ltd, Cardiva Medical Inc
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL EMBOLOTHERAPY MARKET: BY PRODUCT 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product
• 4.2. Embolization Coil Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Embolic Agents Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Detachable Balloons Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Embolic Plug Systems Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.6. Support Devices Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL EMBOLOTHERAPY MARKET: BY APPLICATION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Application
• 5.2. Oncology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Peripheral Vascular Diseases Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Urology and Nephrology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Neurology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. GIT Disorders Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL EMBOLOTHERAPY MARKET: BY PROCEDURE 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Procedure
• 6.2. Transcatheter Arterial Embolization Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Transcatheter Arterial Radioembolization/Selective Internal Radiation Therapy Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Transarterial Chemoembolization Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL EMBOLOTHERAPY MARKET: BY END USER 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast End User
• 7.2. Hospitals and Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Ambulatory Surgical Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Other End Users Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL EMBOLOTHERAPY MARKET: BY REGION 2022-2034(USD MN)

• 8.1. Regional Outlook
• 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.2.1 By Product
  • 8.2.2 By Application
  • 8.2.3 By Procedure
  • 8.2.4 By End User
  • 8.2.5 United States
  • 8.2.6 Canada
  • 8.2.7 Mexico
• 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.3.1 By Product
  • 8.3.2 By Application
  • 8.3.3 By Procedure
  • 8.3.4 By End User
  • 8.3.5 United Kingdom
  • 8.3.6 France
  • 8.3.7 Germany
  • 8.3.8 Italy
  • 8.3.9 Russia
  • 8.3.10 Rest Of Europe
• 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.4.1 By Product
  • 8.4.2 By Application
  • 8.4.3 By Procedure
  • 8.4.4 By End User
  • 8.4.5 India
  • 8.4.6 Japan
  • 8.4.7 South Korea
  • 8.4.8 Australia
  • 8.4.9 South East Asia
  • 8.4.10 Rest Of Asia Pacific
• 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.5.1 By Product
  • 8.5.2 By Application
  • 8.5.3 By Procedure
  • 8.5.4 By End User
  • 8.5.5 Brazil
  • 8.5.6 Argentina
  • 8.5.7 Peru
  • 8.5.8 Chile
  • 8.5.9 South East Asia
  • 8.5.10 Rest of Latin America
• 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.6.1 By Product
  • 8.6.2 By Application
  • 8.6.3 By Procedure
  • 8.6.4 By End User
  • 8.6.5 Saudi Arabia
  • 8.6.6 UAE
  • 8.6.7 Israel
  • 8.6.8 South Africa
  • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

• 9.1. Recent Developments
• 9.2. Company Categorization
• 9.3. Supply Chain & Channel Partners (based on availability)
• 9.4. Market Share & Positioning Analysis (based on availability)
• 9.5. Vendor Landscape (based on availability)
• 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL EMBOLOTHERAPY INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Company Profiles
  • 10.2.1 Boston Medical Corporation
  • 10.2.2 Terumo Corporation
  • 10.2.3 Medtronic Plc
  • 10.2.4 Johnson & Johnson
  • 10.2.5 Stryker Corporation
  • 10.2.6 Sirtex Medical Limited
  • 10.2.7 Abbott Laboratories
  • 10.2.8 Acandis GmbH
  • 10.2.9 Balt Extrusion S.A.S
  • 10.2.10 Cook Medical LLC
  • 10.2.11 Kaneka Corporation
  • 10.2.12 Penumbra Inc
  • 10.2.13 Merit Medical Systems Inc
  • 10.2.14 Meril Life Sciences Pvt. Ltd
  • 10.2.15 Cardiva Medical Inc